Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person trastuzumab:ERBB2 homodimer [plasma membrane]
| Class:Id | Complex:9634469 |
|---|---|
| _displayName | trastuzumab:ERBB2 homodimer [plasma membrane] |
| _timestamp | 2019-01-10 20:15:27 |
| compartment | [Compartment:876] plasma membrane |
| created | [InstanceEdit:9634470] Orlic-Milacic, Marija, 2019-01-10 |
| disease | [Disease:1500689] cancer |
| hasComponent | |
| isChimeric | FALSE |
| name | trastuzumab:ERBB2 homodimer herceptin:ERBB2 homodimer trastuzumab:HER2 homodimer herceptin:HER2 homodimer |
| species | [Species:48887] Homo sapiens |
| stableIdentifier | [StableIdentifier:9634473] R-HSA-9634469.1 |
| (regulator) | [NegativeRegulation:9634468] Negative regulation by 'trastuzumab:ERBB2 homodimer [plasma membrane]' |
| [Change default viewing format] | |
No pathways have been reviewed or authored by trastuzumab:ERBB2 homodimer [plasma membrane] (9634469)
